Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Daniel Mullins

Showing results (201-210 of 287) with videos related to

Pageof 29
Sort By:
Journal of the American College of Surgeons|March 15, 2022
Treat Now or Treat Later: Comparative Effectiveness of Adjuvant Therapy in Resected Stage IIIA MelanomaEmily Z Ma, Julia H Terhune, Zafar Zafari, et al.
Clinical Therapeutics|September 20, 2006
Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureusC Daniel Mullins, Andreas Kuznik, Fadia T Shaya, et al.
Cancer Medicine|July 22, 2014
Cardiovascular event-free survival after adjuvant radiation therapy in breast cancer patients stratified by cardiovascular riskNneka C Onwudiwe, Young Kwok, Eberechukwu Onukwugha, et al.
BMC Medical Research Methodology|August 20, 2015
Measurement of skeletal related events in SEER-Medicare: a comparison of claims-based methodsAbdalla Aly, Eberechukwu Onukwugha, Corinne Woods, et al.
Surgical Infections|March 17, 2016
Evaluation of Tigecycline Efficacy and Post-Discharge Outcomes in a Clinical Practice Population with Complicated Intra-Abdominal Infection: A Propensity Score-Matched AnalysisJoseph Solomkin, C Daniel Mullins, Alvaro Quintana, et al.
Value in Health Regional Issues|April 29, 2018
Guidance Document: Global Pharmacoeconomic Model Adaption StrategiesC Daniel Mullins, Nneka C Onwudiwe, Gabriela Tannus Branco de Araújo, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 15, 2005
Cost-effectiveness of rosuvastatin compared with other statins from a managed care perspectiveJoshua S Benner, Timothy W Smith, David Klingman, et al.
International Journal of Technology Assessment in Health Care|February 9, 2018
PEER-REVIEWED JOURNAL EDITORS' VIEWS ON REAL-WORLD EVIDENCEElisabeth M Oehrlein, Jennifer S Graff, Eleanor M Perfetto, et al.
Clinical Therapeutics|November 22, 2016
Value of Propensity Score Matching for Equalizing Comparator Groups in Observational Database Studies: A Case Study in Anti-infectivesC Daniel Mullins, Frank R Ernst, Michelle R Krukas, et al.
Addictive Behaviors|December 17, 2017
College students' perceived benefit-to-risk tradeoffs for nonmedical use of prescription stimulants: Implications for intervention designsMelissa M Ross, Amelia M Arria, Jessica P Brown, et al.
Pageof 29

Showing results (201-210 of 287) with videos related to

Sort By:
Pageof 29
Journal of the American College of Surgeons|March 15, 2022
Treat Now or Treat Later: Comparative Effectiveness of Adjuvant Therapy in Resected Stage IIIA MelanomaEmily Z Ma, Julia H Terhune, Zafar Zafari, et al.
Clinical Therapeutics|September 20, 2006
Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureusC Daniel Mullins, Andreas Kuznik, Fadia T Shaya, et al.
Cancer Medicine|July 22, 2014
Cardiovascular event-free survival after adjuvant radiation therapy in breast cancer patients stratified by cardiovascular riskNneka C Onwudiwe, Young Kwok, Eberechukwu Onukwugha, et al.
BMC Medical Research Methodology|August 20, 2015
Measurement of skeletal related events in SEER-Medicare: a comparison of claims-based methodsAbdalla Aly, Eberechukwu Onukwugha, Corinne Woods, et al.
Surgical Infections|March 17, 2016
Evaluation of Tigecycline Efficacy and Post-Discharge Outcomes in a Clinical Practice Population with Complicated Intra-Abdominal Infection: A Propensity Score-Matched AnalysisJoseph Solomkin, C Daniel Mullins, Alvaro Quintana, et al.
Value in Health Regional Issues|April 29, 2018
Guidance Document: Global Pharmacoeconomic Model Adaption StrategiesC Daniel Mullins, Nneka C Onwudiwe, Gabriela Tannus Branco de Araújo, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 15, 2005
Cost-effectiveness of rosuvastatin compared with other statins from a managed care perspectiveJoshua S Benner, Timothy W Smith, David Klingman, et al.
International Journal of Technology Assessment in Health Care|February 9, 2018
PEER-REVIEWED JOURNAL EDITORS' VIEWS ON REAL-WORLD EVIDENCEElisabeth M Oehrlein, Jennifer S Graff, Eleanor M Perfetto, et al.
Clinical Therapeutics|November 22, 2016
Value of Propensity Score Matching for Equalizing Comparator Groups in Observational Database Studies: A Case Study in Anti-infectivesC Daniel Mullins, Frank R Ernst, Michelle R Krukas, et al.
Addictive Behaviors|December 17, 2017
College students' perceived benefit-to-risk tradeoffs for nonmedical use of prescription stimulants: Implications for intervention designsMelissa M Ross, Amelia M Arria, Jessica P Brown, et al.
Pageof 29